Tezampanel

CAS : 154652-83-2

Ref. 3D-EGA65283

Informations sur le produit

• Nom: Tezampanel
• Synonymes: (3S,4aR,6R,8aR)-Decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-3-isoquinolinecarboxylic acid, 3-Isoquinolinecarboxylic acid, decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-, (3S,4aR,6R,8aR)-, 3-Isoquinolinecarboxylic acid, decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-, (3S-(3alpha,4aalpha,6beta,8aalpha))-, 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(1H-tetrazol-5-yl)ethyl]-, [3S-(3α,4aα,6β,8aα)]-, 3-Isoquinolinecarboxylic acid, decahydro-6-[2-(2H-tetrazol-5-yl)ethyl]-, (3S,4aR,6R,8aR)-, 6-(2-(1H-Tetrazol-5-yl)ethyl)-1,2,3,4,4a,5,6,7,8,8a-decahydroisoquinoline-3-carboxylic acid, Decahydro-6-(2-(1H-tetrazol-5-yl)ethyl)-3-isoquinolinecarboxylic acid, Ly 293558, Ngx 424, TED-isoquinoline-3-COOH, Tezampanel (anhydrous), Unii-Ga36S2O9C2

Description

Tezampanel is a prodrug that is converted to casopitant mesylate after oral administration. Casopitant mesylate is an experimental drug that acts as a selective antagonist at the NK1 receptor, which is involved in mediating pain and inflammation. Tezampanel has been shown to have antinociceptive properties in animal studies. It also reversibly inhibits the activity of glutamate receptors, including NMDA receptors, which are involved in the development of migraine headaches. Clinical studies have demonstrated that tezampanel may be effective for the treatment of migraine headaches.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 279.34 g/mol
• Formule: C₁₃H₂₁N₅O₂
• Degré de pureté: Min. 95%
• Couleur/Forme: Powder